Rifapentine and isoniazid for prevention of tuberculosis in people with diabetes (PROTID): protocol for a randomised controlled trial

Peer Review reports

Original Submission
4 Mar 2022	Submitted	Original manuscript
9 Mar 2022	Reviewed	Reviewer Report - Kirsty Loudon
8 Apr 2022	Author responded	Author comments - Nyanda Elias Ntinginya
Resubmission - Version 2
8 Apr 2022	Submitted	Manuscript version 2
Publishing
11 Apr 2022	Editorially accepted
10 Jun 2022	Article published	10.1186/s13063-022-06296-8

Back to article page